Suchergebnisse - "Rétinopathie"

PubPharm (27.652)

31

Risk factors for diabetic retinopathy, diabetic macular edema, and sight-threatening diabetic retinopathy

enthalten in: Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) | 2024

von Zhang, G. | Chen, W. | Chen, H. | +8

32

Genetic Association of TIE2 with Diabetic Retinopathy and Diabetic Macular Edema

enthalten in: Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) | 2024

von Yu, J. | Brelen, M. | Chan, C. | +7

33

Lipidomic studies revealing serological markers associated with the occurrence of retinopathy in type 2 diabetes

enthalten in: Journal of translational medicine | 2024

von He, M. | Hou, G. | Liu, M. | +12

34

Unveiling the crucial role of intercellular adhesion molecule-1 in secondary diabetic complications

enthalten in: Cell biochemistry and function | 2024

von Kaur, P. | Dahiya, R. | Nandave, M. | +2

35

Upregulation of HMOX1 associated with M2 macrophage infiltration and ferroptosis in proliferative diabetic retinopathy

enthalten in: International immunopharmacology | 2024

von Zhou, H. | Zhang, L. | Ding, C. | +2

36

AQP4 regulates ferroptosis and oxidative stress of Muller cells in diabetic retinopathy by regulating TRPV4

enthalten in: Experimental cell research | 2024

von Chen, Z. | Liu, B. | Zhou, D. | +4

37

National Eye Institute Biorepository for Retinal Diseases : NEI Intramural Biorepository for Retinal Diseases

enthalten in: ClinicalTrials.gov | 2024

38

Circadian Amplification in Diabetic Retinopathy : Circadian Amplification in Diabetic Retinopathy

enthalten in: ClinicalTrials.gov | 2024

39

A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Moderately Severe to Severe Non-proliferative Diabetic Retinopathy (NPDR) : A Prospective, Randomized, Double-masked, Sham-controlled, Multi-center, Two-arm, Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal Tarcocimab Tedromer in Participants With Moderately Severe to Severe Non-proliferative Diabetic Retinopathy (NPDR) - GLOW2

enthalten in: ClinicalTrials.gov | 2024

40

Erythropoiesis-Stimulating Agents and the Risk of Vision-Threatening Diabetic Retinopathy

enthalten in: Ophthalmic epidemiology | 2024

von Tsui, J. | Willett, K. | Cohen, J. | +2